BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
195 results:

  • 1. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
    Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
    Huang M; Fang W; Farrel A; Li L; Chronopoulos A; Nasholm N; Cheng B; Zheng T; Yoda H; Barata MJ; Porras T; Miller ML; Zhen Q; Ghiglieri L; McHenry L; Wang L; Asgharzadeh S; Park J; Gustafson WC; Matthay KK; Maris JM; Weiss WA
    Cell Rep; 2024 Mar; 43(3):113927. PubMed ID: 38451815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
    Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
    [No Abstract]    [Full Text] [Related]  

  • 5. ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.
    Borenäs M; Umapathy G; Lind DE; Lai WY; Guan J; Johansson J; Jennische E; Schmidt A; Kurhe Y; Gabre JL; Aniszewska A; Strömberg A; Bemark M; Hall MN; Eynden JVD; Hallberg B; Palmer RH
    Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2315242121. PubMed ID: 38154064
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Endothelial-derived small extracellular vesicles support B-cell acute lymphoblastic leukemia development.
    Huang D; Yuan Y; Cao L; Zhang D; Jiang Y; Zhang Y; Chen C; Yu Z; Xie L; Wei Y; Wan J; Zheng J
    Cell Oncol (Dordr); 2024 Feb; 47(1):129-140. PubMed ID: 37751067
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TAL1 hijacks mycn enhancer that induces mycn expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
    Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
    Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
    Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
    Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ALK Gene Mutation and ALK Protein Expression in Advanced Neuroblastoma and the Potential Value in Risk Stratification in Fine-Needle Aspiration Biopsy Samples.
    Bhardwaj N; Rohilla M; Gautam U; Trehan A; Bansal D; Kakkar N; Srinivasan R
    Am J Clin Pathol; 2023 Apr; 159(4):407-415. PubMed ID: 36812383
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults.
    Arniani S; Pierini V; Pellanera F; Matteucci C; Di Giacomo D; Bardelli V; Quintini M; Mavridou E; Lema Fernandez AG; Nardelli C; Moretti M; Gorello P; Crescenzi B; Romoli S; Beacci D; Cerrano M; Fracchiolla N; Sica S; Forghieri F; Giglio F; Dargenio M; Elia L; La Starza R; Mecucci C
    Leukemia; 2022 Nov; 36(11):2577-2585. PubMed ID: 35974102
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aberrant mycn expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.
    Vanden Bempt M; Debackere K; Demeyer S; Van Thillo Q; Meeuws N; Prieto C; Provost S; Mentens N; Jacobs K; Gielen O; Nittner D; Ogawa S; Kataoka K; Graux C; Tousseyn T; Cools J; Dierickx D
    Blood; 2022 Dec; 140(23):2463-2476. PubMed ID: 35960849
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiple cells of origin in common with various types of mouse n-myc acute leukemia.
    Bai H; Zhang Q; Zhang S; Wang J; Luo B; Dong Y; Gao J; Cheng T; Dong F; Ema H
    Leuk Res; 2022 Jun; 117():106843. PubMed ID: 35512442
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients.
    Hua G; Zhang X; Zhang M; Wang Q; Chen X; Yu R; Bao H; Liu J; Wu X; Shao Y; Liang B; Lu K
    ESMO Open; 2022 Feb; 7(1):100337. PubMed ID: 35123209
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform.
    Wu D; Berg J; Arlt B; Röhrs V; Al-Zeer MA; Deubzer HE; Kurreck J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008547
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combined Detection of Copy Number Variations of mycn and ALK using Droplet Digital Polymerase Chain Reaction to Identify High-Risk Patients with Neuroblastoma.
    Trivedi T; Panchal K; Bhalala N; Trivedi P; Panchal H
    World Neurosurg; 2022 Mar; 159():e48-e57. PubMed ID: 34861448
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ATR inhibition enables complete tumour regression in ALK-driven NB mouse models.
    Szydzik J; Lind DE; Arefin B; Kurhe Y; Umapathy G; Siaw JT; Claeys A; Gabre JL; Van den Eynden J; Hallberg B; Palmer RH
    Nat Commun; 2021 Nov; 12(1):6813. PubMed ID: 34819497
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transcriptomic changes during stage progression of mycosis fungoides.
    Xiao MZX; Hennessey D; Iyer A; O'Keefe S; Zhang F; Sivanand A; Gniadecki R
    Br J Dermatol; 2022 Mar; 186(3):520-531. PubMed ID: 34528236
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Frequency and Prognostic Impact of
    Bellini A; Pötschger U; Bernard V; Lapouble E; Baulande S; Ambros PF; Auger N; Beiske K; Bernkopf M; Betts DR; Bhalshankar J; Bown N; de Preter K; Clément N; Combaret V; Font de Mora J; George SL; Jiménez I; Jeison M; Marques B; Martinsson T; Mazzocco K; Morini M; Mühlethaler-Mottet A; Noguera R; Pierron G; Rossing M; Taschner-Mandl S; Van Roy N; Vicha A; Chesler L; Balwierz W; Castel V; Elliott M; Kogner P; Laureys G; Luksch R; Malis J; Popovic-Beck M; Ash S; Delattre O; Valteau-Couanet D; Tweddle DA; Ladenstein R; Schleiermacher G
    J Clin Oncol; 2021 Oct; 39(30):3377-3390. PubMed ID: 34115544
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification.
    Nakazawa A
    Pathol Int; 2021 Apr; 71(4):232-244. PubMed ID: 33657257
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Activated ALK Cooperates with n-myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer.
    Unno K; Chalmers ZR; Pamarthy S; Vatapalli R; Rodriguez Y; Lysy B; Mok H; Sagar V; Han H; Yoo YA; Ku SY; Beltran H; Zhao Y; Abdulkadir SA
    Cancer Res; 2021 Apr; 81(8):2157-2170. PubMed ID: 33637566
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.